Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Association Between Elevated suPAR, a New Biomarker of Inflammation, and Accelerated Aging

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Are Advances in Survival among the Oldest Old Seen across the Spectrum of Health and Functioning?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Age- and Sex-Specific Changes in Lower-Limb Muscle Power Throughout the Lifespan

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The influence of age and cardiorespiratory fitness on bioactive lipids in muscle

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The Relationship between Cognitive Impairment and Upper Extremity Function in Older Primary Care Patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Linking Stressful Life Events and Chronic Inflammation Using suPAR (Soluble Urokinase Plasminogen Activator Receptor)

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Circulating Osteopontin Levels and Outcomes in Patients Hospitalized for COVID-19

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. suPAR Cut-Offs for Risk Stratification in Patients With Symptoms of COVID-19

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: To understand and measure the association between chronic inflammation, aging, and age-related diseases, broadly applicable standard biomarkers of systemic chronic inflammation are needed. We tested whether elevated blood levels of the emerging chronic inflammation marker soluble urokinase plasminogen activator receptor (suPAR) were associated with accelerated aging, lower functional capacity, and cognitive decline.

METHODS: We used data from the Dunedin Study, a population-representative 1972-1973 New Zealand birth cohort (n = 1037) that has observed participants to age 45 years. Plasma suPAR levels were analyzed at ages 38 and 45 years. We performed regression analyses adjusted for sex, smoking, C-reactive protein, and current health conditions.

RESULTS: Of 997 still-living participants, 875 (88%) had plasma suPAR measured at age 45. Elevated suPAR was associated with accelerated pace of biological aging across multiple organ systems, older facial appearance, and with structural signs of older brain age. Moreover, participants with higher suPAR levels had greater decline in physical function and cognitive function from childhood to adulthood compared to those with lower suPAR levels. Finally, improvements in health habits between ages 38 and 45 (smoking cessation or increased physical activity) were associated with less steep increases in suPAR levels over those years.

CONCLUSIONS: Our findings provide initial support for the utility of suPAR in studying the role of chronic inflammation in accelerated aging and functional decline.

OriginalsprogEngelsk
TidsskriftJournals of Gerontology. Series A: Biological Sciences & Medical Sciences
Vol/bind76
Udgave nummer2
Sider (fra-til)318-327
Antal sider10
ISSN1079-5006
DOI
StatusUdgivet - feb. 2021

ID: 60614308